Advertisement

thad balkman

Advertisement
Forbes List Logo
Johnson & Johnson ordered to pay $572 million in landmark opioid trial
A judge wrote that Johnson & Johnson had promulgated "false, misleading, and dangerous marketing campaigns" that had "caused exponentially increasing rates of addiction, overdose deaths" and babies bo
Advertisement
Advertisement
Advertisement